Literature DB >> 22993117

[Genetic testing in hereditary arrythmia syndromes today and in the future].

Britt-Maria Beckmann1, Stefan Kääb.   

Abstract

Genetic testing already has a substantial impact in identifying hereditary arrhythmia syndromes after sudden death in young patients. This report provides information on current developments, available options and reasonable approaches in the clinical setting. In addition the limitations of genetic testing are discussed. Genetic testing is only useful for patients in the context of clinical findings interpreted by an experienced cardiogenetics team.

Entities:  

Mesh：

Year:  2012        PMID： 22993117     DOI： 10.1007/s00399-012-0230-x

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  27 in total

1.  Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.

Authors:  Rong Bai; Carlo Napolitano; Raffaella Bloise; Nicola Monteforte; Silvia G Priori
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-10

2.  Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

Authors:  Hanno L Tan; Nynke Hofman; Irene M van Langen; Allard C van der Wal; Arthur A M Wilde
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

3.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

4.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

5.  Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome.

Authors:  A J Moss; J L Robinson; L Gessman; R Gillespie; W Zareba; P J Schwartz; G M Vincent; J Benhorin; E L Heilbron; J A Towbin; S G Priori; C Napolitano; L Zhang; A Medina; M L Andrews; K Timothy
Journal:  Am J Cardiol       Date:  1999-10-15       Impact factor: 2.778

6.  High distress in parents whose children undergo predictive testing for long QT syndrome.

Authors:  Karin S W H Hendriks; F J M Grosfeld; A A M Wilde; J van den Bout; I M van Langen; J P van Tintelen; H F J ten Kroode
Journal:  Community Genet       Date:  2005

7.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

8.  A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.

Authors:  Jeroen P P Smits; Tamara T Koopmann; Ronald Wilders; Marieke W Veldkamp; Tobias Opthof; Zahir A Bhuiyan; Marcel M A M Mannens; Jeffrey R Balser; Hanno L Tan; Connie R Bezzina; Arthur A M Wilde
Journal:  J Mol Cell Cardiol       Date:  2005-04-01       Impact factor: 5.000

Review 9.  When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias?

Authors:  Steven J Fowler; Carlo Napolitano; Silvia G Priori
Journal:  Curr Opin Cardiol       Date:  2010-01       Impact factor: 2.161

10.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Authors:  Hiroshi Watanabe; Nagesh Chopra; Derek Laver; Hyun Seok Hwang; Sean S Davies; Daniel E Roach; Henry J Duff; Dan M Roden; Arthur A M Wilde; Björn C Knollmann
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.